Biofrontera (BFRI) vs Lantern Pharma (LTRN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Biofrontera (BFRI) has outperformed Lantern Pharma (LTRN) over the past year, losing 10.1% versus a loss of 80.0%. Biofrontera is the larger company by market cap ($13.4 million vs $13.1 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BFRI | LTRN |
|---|---|---|
| Share price | $0.9053 | $0.878 |
| Market cap | $13.45M | $13.11M |
| 1-day change | -3.22% | -3.52% |
| YTD return | +64.11% | -69.97% |
| 1-year return | -10.06% | -80.00% |
| 5-year return | — | -90.91% |
| Forward P/E | 2.11 | — |
| EPS (TTM) | $-0.43 | $-1.63 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $1.66 | $4.69 |
| 52-week low | $0.555 | $0.83 |
| Distance from 52-week high | -45.46% | -81.28% |
| Average volume | 550.61K | 181.84K |
| Shares outstanding | 14.85M | 14.94M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- BFRI has outperformed LTRN by 69.9 percentage points over the past year.
BFRI vs LTRN FAQ
Which is bigger, Biofrontera or Lantern Pharma?
Biofrontera (BFRI) is larger, with a market capitalization of $13.45M compared with $13.11M for Lantern Pharma (LTRN).
Which stock has performed better over the past year, BFRI or LTRN?
BFRI returned -10.06% over the past 12 months, compared with -80.00% for LTRN (price return, excluding dividends). Past performance does not predict future results.
Are Biofrontera and Lantern Pharma in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.